BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 20683574)

  • 1. Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation.
    Huang SH; Chu CH; Yu JC; Chuang WC; Lin GJ; Chen PL; Chou FC; Chau LY; Sytwu HK
    Diabetologia; 2010 Nov; 53(11):2389-400. PubMed ID: 20683574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effect on syngeneic islet transplantation by transgenic coexpression of decoy receptor 3 and heme oxygenase-1 in the islet of NOD mice.
    Huang SH; Lin GJ; Chien MW; Chu CH; Yu JC; Chen TW; Hueng DY; Liu YL; Sytwu HK
    Transplant Proc; 2013 Mar; 45(2):580-4. PubMed ID: 23267792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of thioredoxin in islets transduced by a lentiviral vector prolongs graft survival in autoimmune diabetic NOD mice.
    Chou FC; Sytwu HK
    J Biomed Sci; 2009 Aug; 16(1):71. PubMed ID: 19671194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models.
    McGuire HM; Walters S; Vogelzang A; Lee CM; Webster KE; Sprent J; Christ D; Grey S; King C
    Diabetes; 2011 Mar; 60(3):867-75. PubMed ID: 21357471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection.
    Rønn SG; Börjesson A; Bruun C; Heding PE; Frobøse H; Mandrup-Poulsen T; Karlsen AE; Rasschaert J; Sandler S; Billestrup N
    Diabetologia; 2008 Oct; 51(10):1873-82. PubMed ID: 18648765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
    J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of murine chemokine decoy receptor D6 by islets reveals the role of inflammatory CC chemokines in the development of autoimmune diabetes in NOD mice.
    Lin GJ; Huang SH; Chen YW; Hueng DY; Chia WT; Chien MW; Yen BL; Sytwu HK
    Diabetologia; 2011 Jul; 54(7):1777-87. PubMed ID: 21544515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Introduction of Human Heme Oxygenase-1 and Soluble Tumor Necrosis Factor-α Receptor Type I With Human IgG1 Fc in Porcine Islets Prolongs Islet Xenograft Survival in Humanized Mice.
    Lee HS; Lee JG; Yeom HJ; Chung YS; Kang B; Hurh S; Cho B; Park H; Hwang JI; Park JB; Ahn C; Kim SJ; Yang J
    Am J Transplant; 2016 Jan; 16(1):44-57. PubMed ID: 26430779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.
    Abdulreda MH; Molano RD; Faleo G; Lopez-Cabezas M; Shishido A; Ulissi U; Fotino C; Hernandez LF; Tschiggfrie A; Aldrich VR; Tamayo-Garcia A; Bayer AS; Ricordi C; Caicedo A; Buchwald P; Pileggi A; Berggren PO
    Diabetologia; 2019 Jul; 62(7):1237-1250. PubMed ID: 31087105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide ameliorates autoimmune diabetes and prolongs islet graft survival in nonobese diabetic mice.
    Huang SH; Lin GJ; Chu CH; Yu JC; Chen TW; Chen YW; Chien MW; Chu CC; Sytwu HK
    Pancreas; 2013 Apr; 42(3):442-51. PubMed ID: 23146919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
    Stephens LA; Kay TW
    Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
    Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
    Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of the transgenic expression of human sTNF-αR-Fc and HO-1 on pig-to-mouse islet xenograft survival.
    Yan JJ; Yeom HJ; Jeong JC; Lee JG; Lee EW; Cho B; Lee HS; Kim SJ; Hwang JI; Kim SJ; Lee BC; Ahn C; Yang J
    Transpl Immunol; 2016 Feb; 34():25-32. PubMed ID: 26777482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.
    Gysemans C; Stoffels K; Giulietti A; Overbergh L; Waer M; Lannoo M; Feige U; Mathieu C
    Diabetologia; 2003 Aug; 46(8):1115-23. PubMed ID: 12879250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human Fas ligand on mouse beta islet cells does not induce insulitis but is insufficient to confer immune privilege for islet grafts.
    Hsu PN; Lin HH; Tu CF; Chen NJ; Wu KM; Tsai HF; Hsieh SL
    J Biomed Sci; 2001; 8(3):262-9. PubMed ID: 11385298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
    Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
    Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.